Search

Despite the proven benefits of exercise, even while receiving cancer treatment, new research undertaken by Memorial Sloan Kettering’s Integrative Medicine Service, shows that the majority of cancer patients report significant decreases in their physical activity levels after their cancer diagnosis.

… Wednesday, February 15, 2017 Despite the proven benefits of exercise, even while receiving treatments, new research from Memorial Sloan Kettering’s Integrative Medicine Service shows that the majority of cancer patients report significant decreases in their physical activity levels after their cancer

A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe.

… Thursday, December 1, 2011 Summary A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe. An expert on minimally invasive laser surgery, Snehal G.

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Selwyn M. Vickers, MD, President and CEO of MSK, is among 30 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2024.

… Friday, January 12, 2024 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Selwyn M. Vickers, MD, President and CEO of MSK, is among 30 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2024

SKI Director, Joan Massagué, PhD, is an internationally renowned cancer biologist and leading researcher in the study of cancer metastasis. He is featured in the July 29 MSK Science Spotlight.

… Wednesday, July 29, 2020 SKI Director, Joan Massagué, PhD , is an internationally renowned cancer biologist and leading researcher in the study of cancer metastasis, the cause of 90 percent of cancer deaths. He is featured in the July 29 MSK Science Spotlight . Dr. Massagué studies the control of stem

A team of researchers led by Memorial Sloan Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer.

… Wednesday, July 1, 2009 Summary A team of researchers led by Memorial Sloan Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer. A team of researchers led by Memorial Sloan

It's not only what's inside your cells that determines your cancer risk. It's what surrounds them too.

… Tuesday, June 26, 2018 Summary Scientists are learning that inflammation can play a role in cancer development. This is one example of how the environment surrounding an abnormal cell can influence its fate. Growing up, Philipp Niethammer learned from his mother to never scratch his moles. “I am not

Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas Research Network.

… Wednesday, May 1, 2013 Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center

MSK research provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis of brain diseases by revealing how different parts of the brain are metabolizing nutrients; describes a new method to aid the study of rare but influential cell populations; and identifies a potential treatment for malignant peripheral nerve sheath tumors.

… Friday, January 17, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis

Hedvig Hricak, Chair of Memorial Sloan Kettering's Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors.

… Monday, February 1, 2010 Summary Hedvig Hricak, Chair of Memorial Sloan Kettering’s Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors. Hedvig Hricak , Chair of Memorial Sloan

About two dozen MSK physicians and researchers shared their work at the world’s leading breast cancer conference, held annually in San Antonio.

… Friday, December 13, 2019 At the annual San Antonio Breast Cancer Symposium, MSK investigators presented the latest research on detection and screening methods for people at high risk; immunotherapy for breast cancer; and the underlying causes of resistance to targeted therapies, among other topics.